Manganese(II) nitrate Manganese(II) nitrate Manganese(II) nitrate are the inorganic compounds with formula Mn(NO)(HO). Each formula unit is composed of one Mn cation and two NO anions and varying amounts of water. Most common is the tetrahydrate Mn(NO)·4HO, but mono- and hexahydrates are also known as well as the anhydrous compound. Some of these compounds are useful precursors to the oxides of manganese. Manganese(II) nitrate is prepared by dissolving manganese(II) oxide in nitric acid: It can also be prepared from manganese dioxide and nitrogen dioxide: On heating to 300 °C, aqueous solutions of manganese(II) nitrate thermally decompose to form MnO and NO. Manganese(II)
Manganese alloyed with manganese was harder but not more brittle. In 1837, British academic James Couper noted an association between miners' heavy exposure to manganese with a form of Parkinson's disease. In 1912, United States patents were granted for protecting firearms against rust and corrosion with manganese phosphate electrochemical conversion coatings, and the process has seen widespread use ever since. The invention of the Leclanché cell in 1866 and the subsequent improvement of batteries containing manganese dioxide as cathodic depolarizer increased the demand for manganese dioxide. Until the development of batteries with nickel-cadmium and lithium, most batteries contained manganese. The zinc-carbon